Showing results (1631-1640 of 1,952) with videos related to

Sort By:
Pageof 196
Communications Biology|June 4, 2021
Novel lamprey antibody recognizes terminal sulfated galactose epitopes on mammalian glycoproteinsTanya R McKitrick, Steffen M Bernard, Alexander J Noll, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
SETD2 maintains nuclear lamina stability to safeguard the genomeAbid Khan, James M Metts, Lucas C Collins, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 19, 2016
Revision of the International Pharmaceutical Federation's Basel Statements on the future of hospital pharmacy: From Basel to BangkokLee C Vermeulen, Rebekah J Moles, Jack C Collins, et al.
Nature Communications|March 24, 2026
LysG-driven transcriptional network rewiring underlies lineage-specific phenotypes in Mycobacterium tuberculosisAmir Banaei-Esfahani, Sonia Borrell, Andrej Trauner, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 18, 2014
Increased cerebral vascular reactivity in the tau expressing rTg4510 mouse: evidence against the role of tau pathology to impair vascular health in Alzheimer's diseaseJack A Wells, Holly E Holmes, James M O'Callaghan, et al.
Journal of Geophysical Research. Planets|April 10, 2023
Episodic Plate Tectonics on Europa: Evidence for Widespread Patches of Mobile-Lid Behavior in the Antijovian HemisphereGeoffrey C Collins, G Wesley Patterson, Charlene E Detelich, et al.
Journal of the American Heart Association|October 30, 2018
Breastfeeding History and Risk of Stroke Among Parous Postmenopausal Women in the Women's Health InitiativeLisette T Jacobson, Erinn M Hade, Tracie C Collins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
<i>BIRC6</i> Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate CancerIris Sze Ue Luk, Raunak Shrestha, Hui Xue, et al.
Cancer Cell International|January 15, 2019
Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic targetMarta Llaurado Fernandez, Amy Dawson, Joshua Hoenisch, et al.
Pageof 196